Oncoscope’s optical screening technology is being developed to assist physicians in targeted and efficient examination of a patient’s tissue through guided biopsies. The company is seeking approval from the U.S. Food and Drug Administration to market its device for detecting precancerous lesions of the esophagus, according to the report.
More Articles on Supply Chain:
Medline Launches New Products Catalog
Boston Scientific Looks to Expand Chinese Presence
Supply Chain Efficiency Improved With Inventory Management Intervention
